11 January 2021 | 09:51am StockMarketWire.com - Dietary supplements group OptiBiotix Health said it had agreed to jointly fund and carry out a research project examining the role of its microbiome products to improve sleep, stress, and anxiety. The project partners included Fondazione Edmund Mach - Centro Ricerca e Innovazione, based in Trento, Italy, and the University of Southampton. The research would be performed in the School of Human Development and Health at the University of Southampton and include funding for a related PhD studentship. It would include a double blind, placebo controlled, human study carried out during a period of stress induced sleep disruption.